Alessandrea C. Quane - Sep 5, 2023 Form 4 Insider Report for Oscar Health, Inc. (OSCR)

Role
EVP, Chief Insurance Officer
Signature
/s/ Melissa Curtin, Attorney-in-Fact
Stock symbol
OSCR
Transactions as of
Sep 5, 2023
Transactions value $
-$105,196
Form type
4
Date filed
9/7/2023, 04:28 PM
Previous filing
Sep 6, 2023
Next filing
Dec 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OSCR Class A Common Stock Options Exercise +31.3K +12.34% 284K Sep 5, 2023 Direct F1
transaction OSCR Class A Common Stock Sale -$105K -16.8K -5.9% $6.26 268K Sep 6, 2023 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OSCR Restricted Stock Units Options Exercise $0 -31.3K -16.67% $0.00 156K Sep 5, 2023 Class A Common Stock 31.3K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2 The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.18 to $6.44, inclusive.The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
F4 The restricted stock units vested with respect to 25% of the shares on December 5, 2021, and with respect to the remaining shares in 12 equal quarterly installments thereafter.